tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with Pain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Imam, MZ; Kong, D; Kuo, A; Smith, MT; Williams, CM | 1 |
| Eddinger, KA; Huerta-Esquivel, LL; Kokubu, S; Nguyen, TM; Schiller, PW; Yaksh, TL; Yamaguchi, S | 1 |
| Amiji, MM; Ferris, C; Kulkarni, P; Shah, L | 1 |
3 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and Pain
| Article | Year |
|---|---|
Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources.
Topics: Analgesics, Opioid; Animals; Biological Products; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Discovery; Humans; Ligands; Pain; Peptides; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2022 |
Characterization of the antinociceptive effects of intrathecal DALDA peptides following bolus intrathecal delivery.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Escape Reaction; Fentanyl; Injections, Spinal; Male; Morphine; Oligopeptides; Pain; Pain Measurement; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2019 |
Analgesic efficacy and safety of DALDA peptide analog delivery to the brain using oil-in-water nanoemulsion formulation.
Topics: Analgesics; Animals; Brain; Capsaicin; Disease Models, Animal; Drug Carriers; Emulsions; Magnetic Resonance Imaging; Male; Mice, Inbred Strains; Nanostructures; Oligopeptides; Pain; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2014 |